CareDx, Inc (CDNA)
After hours:
| Previous Close | 21.66 |
| Open | 21.22 |
| Bid | 20.81 x 1400 |
| Ask | 22.05 x 1200 |
| Day's Range | 20.63 - 21.39 |
| 52 Week Range | 19.34 - 81.45 |
| Volume | |
| Avg. Volume | 866,538 |
| Market Cap | 1.11B |
| Beta (5Y Monthly) | 0.88 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.95 |
| Earnings Date | Oct 26, 2022 - Oct 31, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 41.33 |
- Simply Wall St.
CareDx (NASDAQ:CDNA) pulls back 14% this week, but still delivers shareholders incredible 59% CAGR over 5 years
CareDx, Inc ( NASDAQ:CDNA ) shareholders might be concerned after seeing the share price drop 14% in the last quarter...
- Business Wire
CareDx and MOTTEP Co-Host Health Equity Summit
BRISBANE, Calif., August 11, 2022--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that it will co-host, along with MOTTEP (Minority Organ Tissue Transplantation Education Program), a panel discussion, "Tackling Health Equity in Organ Transplantation," on August 18, 2022, 10:00-11:00am PST (1:00–2:00pm EST). The
- Zacks
CareDx (CDNA) Reports Q2 Loss, Lags Revenue Estimates
CareDx (CDNA) delivered earnings and revenue surprises of -62.50% and 3.05%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
